Histocompatibility Testing
"Histocompatibility Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
| Descriptor ID |
D006650
|
| MeSH Number(s) |
E01.370.225.812.385 E05.200.812.385 E05.478.594.385
|
| Concept/Terms |
Histocompatibility Testing- Histocompatibility Testing
- Histocompatibility Testings
- Testing, Histocompatibility
- Testings, Histocompatibility
- Crossmatching, Tissue
- Crossmatchings, Tissue
- Tissue Crossmatching
- Tissue Crossmatchings
- Tissue Typing
- Tissue Typings
- Typing, Tissue
- Typings, Tissue
HLA Typing- HLA Typing
- HLA Typings
- Typing, HLA
- Typings, HLA
|
Below are MeSH descriptors whose meaning is more general than "Histocompatibility Testing".
Below are MeSH descriptors whose meaning is more specific than "Histocompatibility Testing".
This graph shows the total number of publications written about "Histocompatibility Testing" by people in this website by year, and whether "Histocompatibility Testing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Histocompatibility Testing" by people in Profiles.
-
Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Transplantation. 2013 Mar 27; 95(6):852-8.
-
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol. 2004 Dec; 65(12):1506-15.
-
Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine. 2004 May 07; 22(15-16):1914-20.
-
Associations between measles antibody levels and the protein structure of class II human leukocyte antigens. Hum Immunol. 2003 Jul; 64(7):696-707.
-
Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J Infect Dis. 2002 Jun 01; 185(11):1545-9.
-
Changing paternity and the risk of preterm delivery in the subsequent pregnancy. Epidemiology. 1999 Mar; 10(2):148-52.
-
Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int J Infect Dis. 1998 Jan-Mar; 2(3):143-6.